THC Stock Overview
Operates as a diversified healthcare services company in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
My Notes
Capture your thoughts, links and company narrative
Tenet Healthcare Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$137.24 |
| 52 Week High | US$171.20 |
| 52 Week Low | US$88.98 |
| Beta | 2.06 |
| 1 Month Change | 2.09% |
| 3 Month Change | -4.45% |
| 1 Year Change | 48.56% |
| 3 Year Change | 69.01% |
| 5 Year Change | 413.24% |
| Change since IPO | 4,055.33% |
Recent News & Updates
Here's Why Tenet Healthcare (NYSE:THC) Has Caught The Eye Of Investors
Jan 29
Tenet Healthcare Stock: An Improved Option Here (Rating Upgrade)
Dec 30Recent updates
Here's Why Tenet Healthcare (NYSE:THC) Has Caught The Eye Of Investors
Jan 29Tenet Healthcare Stock: An Improved Option Here (Rating Upgrade)
Dec 30Tenet Healthcare: Walk-In Surgical Care Facilities Are A Key Revenue Driver
Dec 17Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden
Nov 17Tenet Healthcare: Targeting More Stable Demand In High-Acuity Services
Nov 04With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case
Oct 30Tenet Healthcare: Becoming A Very Healthy Business
Sep 09Earnings Working Against Tenet Healthcare Corporation's (NYSE:THC) Share Price
Sep 06Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)
Aug 29Here's Why Tenet Healthcare (NYSE:THC) Has A Meaningful Debt Burden
Aug 13An Intrinsic Calculation For Tenet Healthcare Corporation (NYSE:THC) Suggests It's 42% Undervalued
Jul 11Tenet Healthcare: Asset Sales, Current Multiples Support Re-Rating (Rating Upgrade)
Jun 17With EPS Growth And More, Tenet Healthcare (NYSE:THC) Makes An Interesting Case
May 21Tenet Healthcare Corporation's (NYSE:THC) Shareholders Might Be Looking For Exit
Apr 30Does Tenet Healthcare (NYSE:THC) Have A Healthy Balance Sheet?
Mar 18Tenet Healthcare: Shrinking To Grow
Feb 04Tenet Healthcare: A Compelling Opportunity Despite Lofty Debt
Oct 13Tenet Healthcare: Muted Earnings Outlook Doesn't Inspire Confidence For Now
Jul 28Shareholder Returns
| THC | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 2.7% | -2.4% | -0.4% |
| 1Y | 48.6% | -6.7% | 20.8% |
Return vs Industry: THC exceeded the US Healthcare industry which returned -7% over the past year.
Return vs Market: THC exceeded the US Market which returned 23.7% over the past year.
Price Volatility
| THC volatility | |
|---|---|
| THC Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 18.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: THC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: THC's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 86,240 | Saum Sutaria | www.tenethealth.com |
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Tenet Healthcare Corporation Fundamentals Summary
| THC fundamental statistics | |
|---|---|
| Market cap | US$12.90b |
| Earnings (TTM) | US$3.20b |
| Revenue (TTM) | US$20.67b |
4.1x
P/E Ratio0.6x
P/S RatioIs THC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| THC income statement (TTM) | |
|---|---|
| Revenue | US$20.67b |
| Cost of Revenue | US$12.46b |
| Gross Profit | US$8.21b |
| Other Expenses | US$5.01b |
| Earnings | US$3.20b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 33.64 |
| Gross Margin | 39.72% |
| Net Profit Margin | 15.49% |
| Debt/Equity Ratio | 148.9% |
How did THC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/20 00:18 |
| End of Day Share Price | 2025/02/20 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tenet Healthcare Corporation is covered by 43 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Brian Kemp Dolliver | Avondale Partners |
| Hua Ha | Baird |
| Ishan Majumdar | Baptista Research |